RBM23 and breast carcinoma: In addition, an even higher association of IER5 and RBM23 and EIF4A2 were found in breast cancer patients (Fig. S5B, r = 0.75 and p < 0.0001 for RBM23, and r = 0.65 and p < 0.0001 for EIF4A2).